R&D Redefining drug discovery: Morocco’s biotech strategy for in... Ongoing work in Morocco demonstrates how developing research infrastructure can support innovative approaches grounded in locally generated data.
Patients Innovation without access is just a headline: Closing the ga... More than 4.5 billion people - over half the world’s population - lack full coverage of essential health services.
Oncology Disrupting cancer cell division: How tumour treating fields ... Discover how Tumour Treating Fields are transforming pancreatic cancer treatment with insights from Dr. Vincent Picozzi at ASCO 2025.
Sales & Marketing Bad KOL data is expensive: Harnessing high-quality data for ... As biopharmas increasingly rely on AI and advanced data-driven technologies, evaluating the quality of data is critical.
Market Access The outlook for healthtech and life sciences in 2025 2024 was pivotal for UK Life Sciences’ venture funding landscape.
Market Access True innovation in life sciences is only possible through a ... Many of the biggest life sciences breakthroughs are the result of European research.
News AbbVie tries a new approach in 340B programme battle AbbVie has opened a new front in the pharma industry's efforts to reform the 340B drug discounting programme for safety net hospitals in the US.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.